<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01313988</url>
  </required_header>
  <id_info>
    <org_study_id>10018V</org_study_id>
    <nct_id>NCT01313988</nct_id>
  </id_info>
  <brief_title>Efficacy Study on the Lipid-lowering Effect of Plant Sterols and Fish Oil</brief_title>
  <official_title>Efficacy Study on the Lipid-lowering Effect of a Spread Enriched With the Recommended Dose of Plant Sterols and 3 Different Doses of Fatty Acids From Fish Oil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Unilever R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Unilever R&amp;D</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Plant sterols and fish fatty acids are known to affect the blood lipid profile. This
      randomized, double-blind, placebo-controlled, parallel efficacy study is designed to
      investigate the lipid-lowering effect after 4 weeks intervention with the recommended dose of
      plant sterols and different doses of fish fatty acids when combined in a spread format.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in blood lipid profile</measure>
    <time_frame>At baseline (after 4 weeks run-in period) and after 4 weeks intervention</time_frame>
    <description>Includes total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in EPA/DHA in red blood cells</measure>
    <time_frame>At baseline (after 4 weeks run-in period) and after 4 weeks intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in metabolomic parameters</measure>
    <time_frame>At baseline (after 4 weeks run-in period) and after 4 weeks intervention</time_frame>
    <description>For exploratory purposes</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">332</enrollment>
  <condition>Healthy</condition>
  <condition>Mildly Elevated Cholesterol Levels</condition>
  <arm_group>
    <arm_group_label>Dose 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spread that contains plant sterols and fish oil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dose 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spread that contains plant sterols and fish oil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dose 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spread that contains plant sterols and fish oil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo spread</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spread that contains plant sterols</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Plant sterols and fish oil</intervention_name>
    <description>4 weeks intervention, 3 times daily</description>
    <arm_group_label>Dose 1</arm_group_label>
    <arm_group_label>Dose 2</arm_group_label>
    <arm_group_label>Dose 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Plant sterols</intervention_name>
    <description>4 weeks intervention, 3 times daily</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>4 weeks, 3 times daily</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Apparently healthy men and women

          -  Age ≥ 25 and ≤ 75 years old

          -  Body mass index (BMI) ≥ 18 and ≤ 30 kg/m2

          -  Total cholesterol levels at screening ≥ 5.0 and ≤ 8.0 mmol/L

          -  10-year CVD risk equal or lower than 10% according to &quot;SCORE&quot;

          -  Blood pressure, heart rate, hematological parameters, clinical chemical parameters
             within normal reference ranges

          -  Informed consent and biobank consent signed

          -  Willing to comply to study protocol during study

          -  Agreeing to be informed about medically relevant personal test-results by a physician

          -  Not smoking

          -  Accessible veins on the forearm

          -  Habitually consuming spreads

        Exclusion Criteria:

          -  Pregnant or having the wish to become pregnant, or lactating

          -  Use of prescribed medication which may interfere with study measurements

          -  Use of antibiotics in the 3 months before screening or during the study

          -  Use of any medically- or self-prescribed diet with the purpose to reduce weight

          -  Intolerance for gluten or lactose

          -  Reported food allergy

          -  Having bleeding disorders

          -  Recent blood donation

          -  Excessive alcohol consumption

          -  Strenuous exercise

          -  Reported weight change ≥ 10 % of body weight or use of prescribed weight reduction
             drugs

          -  Recent participation in another nutritional or medical trial

          -  Participation in night shift work
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johan Olsson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>KPL Good Food Practice AB</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Birgitta Sundberg, PhD</last_name>
    <role>Study Director</role>
    <affiliation>KPL Good Food Practice AB</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anneli Hallmin</last_name>
    <role>Study Director</role>
    <affiliation>KPL Good Food Practice AB</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>KPL Good Food Practice AB</name>
      <address>
        <city>Uppsala</city>
        <zip>S-751 83</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2011</study_first_submitted>
  <study_first_submitted_qc>March 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2011</study_first_posted>
  <last_update_submitted>February 5, 2012</last_update_submitted>
  <last_update_submitted_qc>February 5, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dose-response study</keyword>
  <keyword>blood lipid profile</keyword>
  <keyword>plant sterols</keyword>
  <keyword>fish oil</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

